Variables | Total | Group A | Group B | Group C | p-value |
---|---|---|---|---|---|
Patients, n | 93 | 31 | 31 | 31 | Â |
Age (years) | Â | Â | Â | Â | 0.50 |
Mean | 66.7 | 68.2 | 67.4 | 64.5 | Â |
Range | 40–90 | 43–83 | 42–90 | 40–89 | |
Sex (n) | Â | Â | Â | Â | 0.81 |
Male | 44 | 16 | 15 | 13 | Â |
Female | 49 | 15 | 16 | 18 | |
Duration of symptoms (months) | Â | Â | Â | Â | 0.92 |
Mean | 10.9 | 10.4 | 11.2 | 11.3 | Â |
Range | 3–24 | 4–18 | 3–24 | 4–22 | |
Diagnosis, n (%) | Â | Â | Â | Â | 0.83 |
Moderate to severe lumbar spinal stenosis | 15 (16.1%) | 7 (22.6%) | 4 (12.9%) | 4 (12.9%) | Â |
Mild spondylolisthesis (Grade I or II) | 23 (24.7%) | 6 (19.4%) | 10 (32.3%) | 7 (22.6%) | |
Giant herniated intervertebral disc with disc space narrowing | 35 (37.6%) | 13 (41.9%) | 11 (35.5%) | 11(35.5%) | |
Lumbar degenerative instability | 11 (11.8%) | 4 (12.9%) | 3 (9.7%) | 4 (12.9%) | |
Postoperative recurrence of lumbar disc herniation | 4 (4.3%) | 1 (3.2%) | 1 (3.2%) | 2 (6.5%) | |
Adjacent segmental disease | 5 (5.4%) | 0 | 2 (6.5%) | 3 (9.7%) | |
Levels Fused, n (%) | Â | Â | Â | Â | 0.01 |
L2-3 | 9 (9.7%) | 2 (6.5%) | 4 (12.9%) | 3 (9.7%) | Â |
L3-4 | 22 (23.7%) | 13 (41.9%) | 2 (6.5%) | 7 (22.6%) | |
L4-5 | 59 (63.4%) | 16 (51.6%) | 25 (80.6%) | 18 (58.1%) | |
L2/3 + L3/4 | 1 (1.1%) | 0 | 0 | 1 (3.2%) | |
L3/4 + L4/5 | 2 (2.2%) | 0 | 0 | 2 (6.5%) |